Literature DB >> 31924129

Cortisol urinary metabolites in dogs with hypercortisolism, congestive heart failure, and healthy dogs: pilot investigation.

Ester Quilez1, Richard K Burchell2, Eric B Thorstensen3, Karin Weidgraaf4, Stacey E Parbhu5, Nicolas Lopez-Villalobos4, Arnon Gal6.   

Abstract

Nonadrenal diseases (NAD), including congestive heart failure (CHF), can affect the conversion of cortisone to cortisol favoring the production of cortisol's urinary downstream metabolites 5α/5β-tetrahydrocortisol (THF) relative to tetrahydrocortisone (THE). We hypothesized that healthy dogs would have lower urinary levels of cortisol, cortisone, THF, and THE than dogs with hypercortisolism (HC) or CHF, and the latter would have higher urinary levels of THF and lower THE than dogs with HC. Four, 9, and 8 dogs with HC, CHF, and normal health, respectively, were included in a pilot prospective cross-sectional study. A single morning voided urine sample was analyzed for urinary cortisol metabolites by liquid chromatography-mass spectrometry. The percentages of conjugated urinary metabolites were significantly higher in dogs with CHF than in healthy dogs (p = 0.001), and not different in HC dogs (p = 0.07). Log-transformed urine cortisol metabolites-to-creatinine ratios in healthy dogs were significantly lower than the 2 other groups (p < 0.001). The urinary free THE:THF ratio was significantly higher (p < 0.001) than the urinary total and conjugated THE:THF ratios. Health status did not affect the total, conjugated, and free THE:THF ratios (p = 0.61). Additional studies are needed to investigate differences in cortisol metabolites between dogs with HC and NAD to accurately discriminate between the groups.

Entities:  

Keywords:  11β-hydroxysteroid dehydrogenase 1; 5α/5β-tetrahydrocortisol; Cushing disease; canine; dogs; liquid chromatography–mass spectrometry; tetrahydrocortisone

Mesh:

Substances:

Year:  2020        PMID: 31924129      PMCID: PMC7081501          DOI: 10.1177/1040638719899645

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  22 in total

Review 1.  The hypothalamic-pituitary-adrenal response to critical illness.

Authors:  I Vermes; A Beishuizen
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-12       Impact factor: 4.690

Review 2.  The use of hair cortisol for the assessment of stress in animals.

Authors:  Susen Heimbürge; Ellen Kanitz; Winfried Otten
Journal:  Gen Comp Endocrinol       Date:  2018-10-02       Impact factor: 2.822

3.  Pituitary ACTH and adrenocortical secretion in critically ill dogs.

Authors:  Jennifer E Prittie; Linda J Barton; Mark E Peterson; Robert J Kemppainen; Leslie G Herr; Philip R Fox
Journal:  J Am Vet Med Assoc       Date:  2002-03-01       Impact factor: 1.936

4.  Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).

Authors:  E N Behrend; H S Kooistra; R Nelson; C E Reusch; J C Scott-Moncrieff
Journal:  J Vet Intern Med       Date:  2013-09-20       Impact factor: 3.333

5.  Vasopressin, cortisol, and catecholamine concentrations in dogs with dilated cardiomyopathy.

Authors:  Anna Tidholm; Jens Häggström; Kerstin Hansson
Journal:  Am J Vet Res       Date:  2005-10       Impact factor: 1.156

6.  Cortisol response in relation to the severity of stress and illness.

Authors:  Isabelle E Widmer; Jardena J Puder; Caroline König; Hans Pargger; Hans Reinhard Zerkowski; Jürg Girard; Beat Müller
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

7.  Evaluation of the urinary cortisol: creatinine ratio in the diagnosis of hyperadrenocorticism in dogs.

Authors:  A L Jensen; L Iversen; J Koch; R Høier; T K Petersen
Journal:  J Small Anim Pract       Date:  1997-03       Impact factor: 1.522

8.  Urinary corticoids in the diagnosis of canine hyperadrenocorticism.

Authors:  R Stolp; A Rijnberk; J C Meijer; R J Croughs
Journal:  Res Vet Sci       Date:  1983-03       Impact factor: 2.534

9.  Pituitary-adrenal axis function in dogs with neoplasia*.

Authors:  A L Boozer; E N Behrend; R J Kemppainen; E M Whitley; A N Smith; K A Busch
Journal:  Vet Comp Oncol       Date:  2005-12       Impact factor: 2.613

10.  Reduced cortisol metabolism during critical illness.

Authors:  Eva Boonen; Hilke Vervenne; Philippe Meersseman; Ruth Andrew; Leen Mortier; Peter E Declercq; Yoo-Mee Vanwijngaerden; Isabel Spriet; Pieter J Wouters; Sarah Vander Perre; Lies Langouche; Ilse Vanhorebeek; Brian R Walker; Greet Van den Berghe
Journal:  N Engl J Med       Date:  2013-03-19       Impact factor: 91.245

View more
  1 in total

1.  Canine urinary lactate and cortisol metabolites in hypercortisolism, nonadrenal disease, congestive heart failure, and health.

Authors:  Arnon Gal; Ryan Fries; Saki Kadotani; Alexander V Ulanov; Zhong Li; J Catharine Scott-Moncrieff; Richard K Burchell; Nicolas Lopez-Villalobos; Yigal Petreanu
Journal:  J Vet Diagn Invest       Date:  2022-06-03       Impact factor: 1.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.